Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system excitation state" refers to a condition or process in which neurons in the CNS are more likely to generate action potentials and increase synaptic transmission. This can result from a reduction in inhibitory signaling, an increase in excitatory neurotransmission, or dysfunction in the molecular components (such as ion channels or neurotransmitter receptors) that regulate neuronal excitability. CNS excitation is not a discrete protein or receptor but a dynamic physiological or pathological state contributing to normal processes like alertness or pathological conditions such as seizures, tremor, or excitotoxic neuronal injury. Drug discovery efforts often aim to modulate CNS excitation through specific molecular targets (e.g., GABA receptors to dampen, glutamate receptors to increase or decrease excitation), but "CNS excitation state" itself is a functional descriptor, not a druggable entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system excitation state.